Establishment of New Intraperitoneal Paclitaxel-Resistant Gastric Cancer Cell Lines and Comprehensive Gene Expression Analysis

Establishment of New Intraperitoneal Paclitaxel-Resistant Gastric Cancer Cell Lines and Comprehensive Gene Expression Analysis

名古屋大学博士学位論文学位の種類:博士(医学) 学位授与年月日:2013-12-27

Bibliographic Details
Main Authors:	村上, 弘城, Murakami, Hiroki
Language:	en
Published:	2013
Online Access:	http://hdl.handle.net/2237/19333

Similar Items

Intraperitoneal Paclitaxel Is Useful as Adjuvant Chemotherapy for Advanced Gastric Cancer with Serosal Exposure
by: Joji Kitayama, et al.
Published: (2014-01-01)

Long-term survival after intraperitoneal chemotherapy with paclitaxel-cisplatin for recurrent primary peritoneal cancer resistant to multiple lines of intravenous chemotherapy
by: Hyejeong Hue, et al.
Published: (2019-07-01)

New and Old Genes Associated with Primary and Established Responses to Paclitaxel Treatment in Ovarian Cancer Cell Lines
by: Monika Świerczewska, et al.
Published: (2018-04-01)

Successful treatment of peritoneal recurrence after gastric cancer surgery with intravenous and intraperitoneal paclitaxel combined with S-1 chemotherapy: a case report
by: Kozo Miyatani, et al.
Published: (2020-05-01)

Does adding intraperitoneal paclitaxel to standard intraperitoneal regimen yield incremental survival? A propensity score-matched cohort study
by: Yen-Hou Chang, et al.
Published: (2016-05-01)

Intraperitoneal explosion following gastric perforation
by: Scott K. Mansfield, et al.
Published: (2014-04-01)

Role of intraperitoneal chemotherapy in gastric cancer
by: Amir Parray, et al.
Published: (2021-03-01)

Paclitaxel loaded poly(L-lactic acid)microspheres : characterisation and intraperitoneal administration
by: Liggins, Richard
Published: (2009)

Paclitaxel loaded poly(L-lactic acid)microspheres : characterisation and intraperitoneal administration
by: Liggins, Richard
Published: (2009)

Phase II study of intraperitoneal submicron particle paclitaxel (SPP) plus IV carboplatin and paclitaxel in patients with epithelial ovarian cancersurgery
by: Sally Mullany, et al.
Published: (2020-11-01)

TWIST mediates resistance to paclitaxel by regulating Akt and Bcl-2 expression in gastric cancer cells
by: Chae Hwa Kwon, et al.
Published: (2017-10-01)

Comprehensive molecular characterization of gastric cancer patients from phase II second-line ramucirumab plus paclitaxel therapy trial
by: Seung Tae Kim, et al.
Published: (2021-01-01)

Pathological complete response after intraperitoneal paclitaxel and systemic combined chemotherapy in a patient with peritoneal metastases from gastric cancer: a case report
by: Yoshiyuki Meguro, et al.
Published: (2020-03-01)

Studies of Gastric Tumor Metastasis-Associated Genes and Paclitaxel Treatment on Gastric Tumor Metastasis
by: Tsung-Fan Tuan, et al.
Published: (2013)

Severe hypertriglyceridemia during treatment with intraperitoneal cisplatin and paclitaxel for advanced stage fallopian tube carcinoma
by: Megan Lander, et al.
Published: (2020-05-01)

Intraperitoneal cancer-immune microenvironment promotes peritoneal dissemination of gastric cancer
by: Shuichi Sakamoto, et al.
Published: (2019-12-01)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer
by: Adriana C. Gamboa, et al.
Published: (2019-10-01)

Ramucirumab combined with paclitaxel as the second-line chemotherapy for elderly patients with disseminated gastric cancer
by: T. A. Titova, et al.
Published: (2018-07-01)

Mir-26b inhibits growth and resistance to paclitaxel chemotherapy by silencing the CDC6 gene in gastric cancer
by: Bochao Zhao, et al.
Published: (2018-02-01)

Effects of Female Sex Hormones on Clusterin Expression and Paclitaxel Resistance in Endometrial Cancer Cell Lines
by: Yong Sung Won, Sung Jong Lee, Seung Geun Yeo, Dong Choon Park
Published: (2012-01-01)

New Insights in Gene Expression Alteration as Effect of Paclitaxel Drug Resistance in Triple Negative Breast Cancer Cells
by: Ancuta Jurj, et al.
Published: (2020-07-01)

Randomized Phase II trial of paclitaxel plus valproic acid vs paclitaxel alone as second-line therapy for patients with advanced gastric cancer
by: Fushida S, et al.
Published: (2015-04-01)

The Role of Matrix Gla Protein (MGP) Expression in Paclitaxel and Topotecan Resistant Ovarian Cancer Cell Lines
by: Karolina Sterzyńska, et al.
Published: (2018-09-01)

Paclitaxel plus valproic acid versus paclitaxel alone as second- or third-line therapy for advanced gastric cancer: a randomized Phase II trial
by: Fushida S, et al.
Published: (2016-07-01)

Establishment and characterization of a new gastric cancer cell line, XGC-1
by: Jigui Peng, et al.
Published: (2020-09-01)

Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer
by: Mashiro Okunaka, et al.
Published: (2020-11-01)

Clinical example of enhancing efficacy of paclitaxel by combining it with ramuchirumabin in the second-line chemotherapy of disseminated gastric cancer
by: T. A. Titova, et al.
Published: (2019-06-01)

Cytosolic Cl- Affects the Anticancer Activity of Paclitaxel in the Gastric Cancer Cell Line, MKN28 Cell
by: Sachie Tanaka, et al.
Published: (2017-05-01)

Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin
by: Sherman-Baust Cheryl A, et al.
Published: (2011-12-01)

OUR EXPERIENCE OF HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY FOR PATIENTS WITH ADVANCED GASTRIC CANCER
by: A. D. Kaprin, et al.
Published: (2016-01-01)

Achillin Increases Chemosensitivity to Paclitaxel, Overcoming Resistance and Enhancing Apoptosis in Human Hepatocellular Carcinoma Cell Line Resistant to Paclitaxel (Hep3B/PTX)
by: Jessica Nayelli Sanchez-Carranza, et al.
Published: (2019-10-01)

Clusterin Interacts with Paclitaxel and Confer Paclitaxel Resistance in Ovarian Cancer
by: Dong Choon Park, et al.
Published: (2008-09-01)

Metabolic Adaptation during nab-Paclitaxel Resistance in Pancreatic Cancer Cell Lines
by: Lukas M. Braun, et al.
Published: (2020-05-01)

Resistance to paclitaxel in a cisplatin-resistant ovarian cancer cell line is mediated by P-glycoprotein.
by: Britta Stordal, et al.
Published: (2012-01-01)

Down-regulated βIII-tubulin Expression Can Reverse Paclitaxel Resistance in A549/Taxol Cells Lines
by: Yinling ZHUO, et al.
Published: (2014-08-01)

Characteristics of the Drug Resistant Gene Expression of A Newly Established Renal Cell Carcinoma Cell Line
by: 邱炫道
Published: (1997)

Thymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel
by: Shen Lin, et al.
Published: (2011-05-01)

Prophylactic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer—A Systematic Review
by: H. J. F. Brenkman, et al.
Published: (2019-10-01)

Gastric cancer with high risk of intraperitoneal progression: clinical course and current treatments
by: Yarema Roman
Published: (2017-12-01)

Apatinib enhances chemosensitivity of gastric cancer to paclitaxel and 5-fluorouracil
by: Xu Z, et al.
Published: (2019-05-01)

Cannot write session to /tmp/vufind_sessions/sess_kgkfmc5sn5kkpcdu16vn755c2k